(Q38328986)

English

Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

monoclonal antibody

1 reference

based on heuristic

inferred from title

Laurence Briant

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Thierry Chardès

0 references

author name string

Monnet C

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Laune D

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Laroche-Traineau J

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Biard-Piechaczyk M

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Bès C

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Pugnière M

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Mani JC

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Pau B

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Cerutti M

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Devauchelle G

11

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Devaux C

12

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Granier C

13

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Chardès T

14

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

274

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

3789-3796

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

The structure of the CD4 and CD8 genes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Crystal structure of an HIV-binding recombinant fragment of human CD4.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Identification of the residues in human CD4 critical for the binding of HIV.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Transduction of Activation Signal That Follows HIV-1 Binding to CD4 and CD4 Dimerization Involves the Immunoglobulin CDR3-like Region in Domain 1 of CD4

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Development of biologically active peptides based on antibody structure

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Specific Binding of a Synthetic Peptide Derived from an Antibody Complementarity Determining Region to Phosphatidylserine

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

A synthetic peptide with anti-platelet activity derived from a CDR of an anti-GPIIb-IIIa antibody.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Functional expression of the CD4 protein after cross-linking to red blood cells with a bifunctional reagent.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

A sensitive method for localization of disulfide containing peptides in column effluents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Antibody-structure-based design of pharmacological agents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Bound water molecules and conformational stabilization help mediate an antigen-antibody association

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Design and synthesis of a mimetic from an antibody complementarity-determining region.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Kinetic and Concentration Analysis Using BIA Technology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Inhibition of Self-Binding Antibodies (Autobodies) by a V H -Derived Peptide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

A ten-residue fragment of an antibody (mini-antibody) directed against lysozyme as ligand in immunoaffinity chromatography

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Sequence and linkage of the V kappa 21A and G germ-line gene segments in the mouse

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Antibody framework residues affecting the conformation of the hypervariable loops

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.6.3789

21 January 2018

Identifiers

10.1074/JBC.274.6.3789

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38328986&oldid=1753708132"